Warnings: In one study of people who experienced a heart attack within the past 2 years, those who were prescribed flecainide were more likely to have another heart attack or die than those who did not take flecainide
Medications include brand-name Wegovy, compounded semaglutide, and brand-name Zepbound via insurance (see our tirzepatide vs semaglutide breakdown)
however, no significant changes were observed in LDL or total cholesterol.28 A 2022 meta-analysis focusing on adults with metabolic syndrome risk factors reached similar conclusions, noting modest reductions in LDL cholesterol and systolic blood pressure but overall marginal changes in total cholesterol.29 A broader 2024 review summarizing human and preclinical data suggests that astaxanthin may enhance insulin sensitivity and glucose uptake while supporting lipid metabolism and antioxidant balance, though these findings are based on limited trials and changes in biomarkers.30 These effects are thought to involve activation of Nrf2, a cellular pathway that turns on the bodys own antioxidant defenses, and improved mitochondrial energy metabolism, which may help regulate oxidative stress
Transitions of the loop can be monitored via the central reporter residue I353
Consistency matters far more than the specific day
Post-marketing surveillance reports for GLP-1 receptor agonists
